Summary:
The aim of this phase III trial is to demonstrate the equivalence in the safety and efficacy of an investigational medication as compared to a bolus insulin.
Qualified Participants Must:
• Age 18+
•
Diagnosed with type 1 diabetes
•
Currently taking basal/bolus insulin regimen
Qualified Participants May Receive:
- Glucometer and supplies
- investigational medication
- Study related evaluations